Shear Stress and Sub-Femtomolar Levels of Ligand Synergize to Activate ALK1 Signaling in Endothelial Cells
Cells · 2024
DOI: 10.3390/cells13030285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Ya-Wen Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15261, USA. Hauptthemen laut MEDLINE: Telangiectasia, Hereditary Hemorrhagic, Arteriovenous Malformations. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NHLBI NIH HHS, Leonard H. Berenfield Graduate Fellowship.
Abstract (Originalsprache)
Endothelial cells (ECs) respond to concurrent stimulation by biochemical factors and wall shear stress (SS) exerted by blood flow. Disruptions in flow-induced responses can result in remodeling issues and cardiovascular diseases, but the detailed mechanisms linking flow-mechanical cues and biochemical signaling remain unclear. Activin receptor-like kinase 1 (ALK1) integrates SS and ALK1-ligand cues in ECs; ALK1 mutations cause hereditary hemorrhagic telangiectasia (HHT), marked by arteriovenous malformation (AVM) development. However, the mechanistic underpinnings of ALK1 signaling modulation by fluid flow and the link to AVMs remain uncertain. We recorded EC responses under varying SS magnitudes and ALK1 ligand concentrations by assaying pSMAD1/5/9 nuclear localization using a custom multi-SS microfluidic device and a custom image analysis pipeline. We extended the previously reported synergy between SS and BMP9 to include BMP10 and BMP9/10. Moreover, we demonstrated that this synergy is effective even at extremely low SS magnitudes (0.4 dyn/cm2) and ALK1 ligand range (femtogram/mL). The synergistic response to ALK1 ligands and SS requires the kinase activity of ALK1. Moreover, ALK1’s basal activity and response to minimal ligand levels depend on endocytosis, distinct from cell–cell junctions, cytoskeleton-mediated mechanosensing, or cholesterol-enriched microdomains. However, an in-depth analysis of ALK1 receptor trafficking’s molecular mechanisms requires further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15261, USA.
- Department of Human Genetics, School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA.
- Department of Structural Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
- Heart, Lung, Blood and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA 15261, USA.
- Department of Developmental Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
- Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
ORCID-Profile: Andrew P Hinck, Beth L Roman, Lance A Davidson
Förderung
- NICHD NIH HHS
- NHLBI NIH HHS
- Leonard H. Berenfield Graduate Fellowship
Zitieren
APA
Cheng, Y. W., Anzell, A. R., Morosky, S. A., Schwartze, T. A., Hinck, C. S., Hinck, A. P., Roman, B. L., & Davidson, L. A. (2024). Shear Stress and Sub-Femtomolar Levels of Ligand Synergize to Activate ALK1 Signaling in Endothelial Cells. Cells. https://doi.org/10.3390/cells13030285
Vancouver
Cheng YW, Anzell AR, Morosky SA, Schwartze TA, Hinck CS, Hinck AP, et al. Shear Stress and Sub-Femtomolar Levels of Ligand Synergize to Activate ALK1 Signaling in Endothelial Cells. Cells. 2024. doi:10.3390/cells13030285
BibTeX
@article{Cheng2024,
author = {Cheng, Ya-Wen and Anzell, Anthony R and Morosky, Stefanie A and Schwartze, Tristin A and Hinck, Cynthia S and Hinck, Andrew P and Roman, Beth L and Davidson, Lance A},
title = {Shear Stress and Sub-Femtomolar Levels of Ligand Synergize to Activate ALK1 Signaling in Endothelial Cells},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13030285}
}
EUVIMED